Haemodialysis in haemophilia B: a case report. Challenges and strategies from a nephrology perspective.

J NephrolOct 30, 2026

Chiara Terzo, Rosario Maccarrone, Sandra La Rosa et al.

✦ AI-curated · Sources linked

Case in brief

A 68-year-old man with severe haemophilia B and kidney failure required kidney replacement therapy. He received prophylactic Idelvion® (albutrepenonacog alfa), then underwent arteriovenous fistula creation and started haemodialysis. No bleeding complications were reported. The report also reviews dialysis considerations in haemophilia B, including modality selection, vascular access, factor IX replacement and anticoagulation, and describes multidisciplinary planning to reduce bleeding risk.

What made this case unusual

The case demonstrates haemodialysis initiation, including arteriovenous fistula creation, in a patient with severe haemophilia B without reported bleeding complications under prophylactic factor IX replacement.

Diagnostic / clinical pearl

Severe haemophilia B does not necessarily preclude chronic haemodialysis; this case highlights the role of multidisciplinary planning, factor IX replacement and tailored anticoagulation to address bleeding risk.

Source

Published in J Nephrol. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Nephrology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.